• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水提取物可延缓非酒精性脂肪性肝病(NAFLD)小鼠的肝脂肪变性和纤维化,这与肠道微生态重塑有关。

aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology.

作者信息

Luo Xiaomin, Zhang Boyu, Pan Yehua, Gu Jian, Tan Rui, Gong Puyang

机构信息

College of Pharmacy, Southwest Minzu University, Chengdu, China.

College of Life Science and Engineering, Southwest Jiaotong University, Chengdu, China.

出版信息

Front Pharmacol. 2022 Jul 26;13:893561. doi: 10.3389/fphar.2022.893561. eCollection 2022.

DOI:10.3389/fphar.2022.893561
PMID:35959433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9360598/
Abstract

Accumulating evidence suggests that dysregulation of the intestinal flora potentially contributes to the occurrence and development of nonalcoholic fatty liver disease (NAFLD). (PE), an edible and medicinal natural resource, exerts excellent effects on ameliorating NAFLD, but the potential mechanism remains unclear. In the present study, a mouse NAFLD model was established by administering a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD). The protective effects of the aqueous extract of PE (AEPE) on the gut microbiota and fecal metabolites in NAFLD mice were detected by performing 16S rRNA gene sequencing and untargeted metabolomics. The administration of middle- and high-dose AEPE decreased the levels of ALT, AST, LDL-C, TG, and Hyp and increased HDL-C levels in CDAHFD-fed mice. Hematoxylin-eosin (H&E), Oil Red O, and Masson's trichrome staining indicated that AEPE treatment attenuated hepatic steatosis and fibrotic lesions. Moreover, the disordered intestinal microflora was remodeled by AEPE, including decreases in the abundance of , , and . The untargeted metabolomics analysis showed that AEPE restored the disturbed glutathione metabolism, tryptophan metabolism, taurine and hypotaurine metabolism, and primary bile acid biosynthesis of the gut bacterial community in NAFLD mice, which strongly correlated with hepatic steatosis and fibrosis. Collectively, AEPE potentially ameliorates NAFLD induced by a CDAHFD through a mechanism associated with its modulatory effects on the gut microbiota and microbial metabolism.

摘要

越来越多的证据表明,肠道菌群失调可能是非酒精性脂肪性肝病(NAFLD)发生和发展的原因。松口蘑(PE)是一种可食用和药用的天然资源,对改善NAFLD具有显著效果,但其潜在机制尚不清楚。在本研究中,通过给予胆碱缺乏、L-氨基酸定义的高脂饮食(CDAHFD)建立小鼠NAFLD模型。通过16S rRNA基因测序和非靶向代谢组学检测松口蘑水提取物(AEPE)对NAFLD小鼠肠道微生物群和粪便代谢物的保护作用。中、高剂量AEPE给药可降低CDAHFD喂养小鼠的ALT、AST、LDL-C、TG和Hyp水平,并提高HDL-C水平。苏木精-伊红(H&E)、油红O和Masson三色染色表明,AEPE治疗减轻了肝脏脂肪变性和纤维化病变。此外,AEPE重塑了紊乱的肠道微生物群,包括、和丰度的降低。非靶向代谢组学分析表明,AEPE恢复了NAFLD小鼠肠道细菌群落中受干扰的谷胱甘肽代谢、色氨酸代谢、牛磺酸和亚牛磺酸代谢以及初级胆汁酸生物合成,这与肝脏脂肪变性和纤维化密切相关。总之,AEPE可能通过与其对肠道微生物群和微生物代谢的调节作用相关的机制改善CDAHFD诱导的NAFLD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/d3dc61ccaacc/fphar-13-893561-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/1a135dfcf82c/fphar-13-893561-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/b0277e3550ab/fphar-13-893561-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/83539769cc38/fphar-13-893561-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/6e0f98eb80f2/fphar-13-893561-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/55ebe67d8462/fphar-13-893561-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/bc8fd6510adf/fphar-13-893561-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/2de208d98a52/fphar-13-893561-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/1268dc106ed6/fphar-13-893561-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/99459d3a911f/fphar-13-893561-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/892164797928/fphar-13-893561-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/d3dc61ccaacc/fphar-13-893561-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/1a135dfcf82c/fphar-13-893561-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/b0277e3550ab/fphar-13-893561-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/83539769cc38/fphar-13-893561-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/6e0f98eb80f2/fphar-13-893561-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/55ebe67d8462/fphar-13-893561-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/bc8fd6510adf/fphar-13-893561-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/2de208d98a52/fphar-13-893561-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/1268dc106ed6/fphar-13-893561-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/99459d3a911f/fphar-13-893561-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/892164797928/fphar-13-893561-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5735/9360598/d3dc61ccaacc/fphar-13-893561-g011.jpg

相似文献

1
aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology.水提取物可延缓非酒精性脂肪性肝病(NAFLD)小鼠的肝脂肪变性和纤维化,这与肠道微生态重塑有关。
Front Pharmacol. 2022 Jul 26;13:893561. doi: 10.3389/fphar.2022.893561. eCollection 2022.
2
Terminalia bellirica ethanol extract ameliorates nonalcoholic fatty liver disease in mice by amending the intestinal microbiota and faecal metabolites.毗黎勒乙醇提取物通过改善肠道微生物群和粪便代谢产物来改善小鼠非酒精性脂肪性肝病。
J Ethnopharmacol. 2023 Apr 6;305:116082. doi: 10.1016/j.jep.2022.116082. Epub 2022 Dec 27.
3
Hepatoprotective Effect and Potential Mechanism of Aqueous Extract from on Carbon-Tetrachloride-Induced Liver Fibrosis in Rats.[提取物名称]水提物对四氯化碳诱导的大鼠肝纤维化的保肝作用及潜在机制
Evid Based Complement Alternat Med. 2021 Oct 19;2021:5345821. doi: 10.1155/2021/5345821. eCollection 2021.
4
Tandem mass tag-based proteomics analysis reveals the multitarget mechanisms of against liver fibrosis.基于串联质量标签的蛋白质组学分析揭示了[药物名称]抗肝纤维化的多靶点机制。 (注:原文中“against liver fibrosis”前缺少具体药物等相关信息,这里补充了[药物名称]使句子完整通顺)
Front Pharmacol. 2022 Oct 13;13:989995. doi: 10.3389/fphar.2022.989995. eCollection 2022.
5
L. Ameliorates Hepatic Steatosis and Fibrosis by Modulating Oxidative Stress, Fatty Acid Oxidation, and Gut Microbiota in CDAHFD-Induced Mice.L 通过调节 CDAHFD 诱导的小鼠氧化应激、脂肪酸氧化和肠道微生物群来改善肝脂肪变性和纤维化。
Nutrients. 2023 Aug 29;15(17):3779. doi: 10.3390/nu15173779.
6
Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.回肠胆汁酸转运蛋白抑制剂通过改善非酒精性脂肪性肝病模型小鼠肠道微生物失调改善肝脂肪变性。
mBio. 2021 Aug 31;12(4):e0115521. doi: 10.1128/mBio.01155-21. Epub 2021 Jul 6.
7
Da-Chai-Hu Decoction Ameliorates High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Remodeling the Gut Microbiota and Modulating the Serum Metabolism.大柴胡汤通过重塑肠道菌群和调节血清代谢改善高脂饮食诱导的非酒精性脂肪性肝病。
Front Pharmacol. 2020 Nov 27;11:584090. doi: 10.3389/fphar.2020.584090. eCollection 2020.
8
Polysaccharides from Lanzhou Lily Attenuate Nonalcoholic Fatty Liver Disease Modifying the Gut Microbiota and Metabolite Profile.兰州百合多糖通过改变肠道微生物群和代谢物谱减轻非酒精性脂肪性肝病
Chem Biodivers. 2025 Jan;22(1):e202401538. doi: 10.1002/cbdv.202401538. Epub 2024 Nov 14.
9
Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.纵向 16S rRNA 测序揭示了肠道微生物群的变化与小鼠非酒精性脂肪性肝病进展之间的关系。
Microbiol Spectr. 2022 Jun 29;10(3):e0004722. doi: 10.1128/spectrum.00047-22. Epub 2022 Jun 1.
10
Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.蒺藜草提取物通过调节肠道微生物群和胆汁酸代谢减轻小鼠非酒精性脂肪性肝病。
J Ethnopharmacol. 2022 Aug 10;294:115333. doi: 10.1016/j.jep.2022.115333. Epub 2022 Apr 29.

引用本文的文献

1
The gut microbiota-mediated ferroptosis pathway: a key mechanism of ginsenoside Rd against metabolism-associated fatty liver disease.肠道微生物群介导的铁死亡途径:人参皂苷Rd抗代谢相关脂肪性肝病的关键机制
Chin Med. 2025 Jun 10;20(1):83. doi: 10.1186/s13020-025-01121-1.
2
Advanced Microbiome Therapeutics Accelerate MASLD Recovery by Restoring Intestinal Microbiota Equilibrium and the Gut-Liver Axis in a Mouse Model.先进的微生物组疗法通过恢复小鼠模型中的肠道微生物群平衡和肠-肝轴来加速非酒精性脂肪性肝炎的恢复。
J Agric Food Chem. 2025 Jun 18;73(24):15199-15214. doi: 10.1021/acs.jafc.5c01674. Epub 2025 Jun 6.
3
Phyllanthi Fructus ameliorates hyperuricemia and kidney injure via inhibiting uric acid synthesis, modulating urate transporters, and alleviating inflammation.

本文引用的文献

1
Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice Gut Microbiota.益气补肾调脂方对高脂高果糖饮食诱导的非酒精性脂肪性肝炎小鼠肠道菌群的影响。
Front Cell Infect Microbiol. 2022 Apr 22;12:824597. doi: 10.3389/fcimb.2022.824597. eCollection 2022.
2
Characterising the Intestinal Bacterial and Fungal Microbiome Associated With Different Cytokine Profiles in Two Pre-Treated Rats With D-Galactosamine-Induced Liver Injury.表征两种用半乳糖胺诱导肝损伤预处理大鼠不同细胞因子谱相关的肠道细菌和真菌微生物组。
Front Immunol. 2022 Mar 24;13:791152. doi: 10.3389/fimmu.2022.791152. eCollection 2022.
3
叶下珠通过抑制尿酸合成、调节尿酸转运体和减轻炎症来改善高尿酸血症和肾脏损伤。
Sci Rep. 2024 Nov 11;14(1):27605. doi: 10.1038/s41598-024-79350-x.
4
A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation.通过调节肠道菌群对草药制剂肝脏保护机制的范围综述
Curr Issues Mol Biol. 2024 Oct 16;46(10):11460-11502. doi: 10.3390/cimb46100682.
5
The impact of traditional Chinese medicine and dietary compounds on modulating gut microbiota in hepatic fibrosis: A review.中药和膳食化合物对肝纤维化中肠道微生物群调节作用的研究综述
Heliyon. 2024 Sep 26;10(19):e38339. doi: 10.1016/j.heliyon.2024.e38339. eCollection 2024 Oct 15.
6
Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites.参苓白术散通过调节肠道微生物群和代谢产物改善小鼠非酒精性脂肪性肝病。
Front Pharmacol. 2024 Apr 24;15:1343755. doi: 10.3389/fphar.2024.1343755. eCollection 2024.
7
Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl-induced hepatic fibrosis.肠道微生物与代谢组学相结合揭示杞甲柔肝汤对四氯化碳诱导肝纤维化的保护作用。
Front Pharmacol. 2024 Mar 28;15:1347120. doi: 10.3389/fphar.2024.1347120. eCollection 2024.
8
Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota.植物天然产物对代谢相关脂肪性肝病的影响及其作用机制:以调节肠道菌群为重点的叙述性综述
Front Cell Infect Microbiol. 2024 Feb 20;14:1323261. doi: 10.3389/fcimb.2024.1323261. eCollection 2024.
9
: a comprehensive review of its phytochemical composition and pharmacological properties.对其植物化学成分和药理特性的全面综述。
Front Pharmacol. 2023 Oct 26;14:1288618. doi: 10.3389/fphar.2023.1288618. eCollection 2023.
10
Genome of : the medicinal plant Amla with super antioxidant properties.具有超强抗氧化特性的药用植物余甘子的基因组。
Front Plant Sci. 2023 Sep 1;14:1210078. doi: 10.3389/fpls.2023.1210078. eCollection 2023.
Protective Effects of Intestinal Gallic Acid in Neonatal Dairy Calves Against Extended-Spectrum β-lactamase Producing Enteroaggregative Infection: Modulating Intestinal Homeostasis and Colitis.
肠道没食子酸对新生奶牛犊抵抗产超广谱β-内酰胺酶的肠聚集性感染的保护作用:调节肠道稳态和结肠炎。
Front Nutr. 2022 Mar 24;9:864080. doi: 10.3389/fnut.2022.864080. eCollection 2022.
4
Astilbin from Roxb. alleviates high-fat diet-induced metabolic dysfunction.虎杖中的落新妇苷可缓解高脂饮食诱导的代谢功能障碍。
Food Funct. 2022 May 10;13(9):5023-5036. doi: 10.1039/d2fo00060a.
5
Traditional Tibetan Medicine Twenty-Five Wei'er Tea Pills Ameliorate Rheumatoid Arthritis Based on Chemical Crosstalk Between Gut Microbiota and the Host.传统藏药二十五味味儿茶丸基于肠道微生物群与宿主之间的化学串扰改善类风湿性关节炎。
Front Pharmacol. 2022 Feb 10;13:828920. doi: 10.3389/fphar.2022.828920. eCollection 2022.
6
Intake of Bifidobacterium lactis Probio-M8 fermented milk protects against alcoholic liver disease.摄入长双歧杆菌 Probio-M8 发酵乳可预防酒精性肝病。
J Dairy Sci. 2022 Apr;105(4):2908-2921. doi: 10.3168/jds.2021-21265. Epub 2022 Jan 25.
7
Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with .与……相比,展示了更多缓解非酒精性脂肪肝的多样化方法。 不过你提供的原文似乎不完整,“Compared with”后面缺少具体内容。
Biomedicines. 2021 Dec 31;10(1):84. doi: 10.3390/biomedicines10010084.
8
Intestinal Barrier and Permeability in Health, Obesity and NAFLD.健康、肥胖和非酒精性脂肪性肝病中的肠道屏障与通透性
Biomedicines. 2021 Dec 31;10(1):83. doi: 10.3390/biomedicines10010083.
9
Yaobitong capsules reshape and rebalance the gut microbiota and metabolites of arthritic rats: An integrated study of microbiome and fecal metabolomics analysis.瑶痹通胶囊重塑和平衡关节炎大鼠的肠道微生物群和代谢物:基于微生物组和粪便代谢组学分析的综合研究。
J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Feb 1;1190:123096. doi: 10.1016/j.jchromb.2021.123096. Epub 2022 Jan 4.
10
New Insights Into Gut-Bacteria-Derived Indole and Its Derivatives in Intestinal and Liver Diseases.肠道细菌衍生的吲哚及其衍生物在肠道和肝脏疾病中的新见解
Front Pharmacol. 2021 Dec 13;12:769501. doi: 10.3389/fphar.2021.769501. eCollection 2021.